Doctor profile · Federal record

Dr. Rachel Rigo, MD

Dermatology Physician (CMS: Dermatology) · Palo Alto, CA

  • NPI 1902399751
  • Accepts Medicare
  • 8 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

Operates at 2 locations .

NPPES Updated May 11, 2026
Primary practice
795 El Camino Real
Palo Alto, CA 943012302
(650) 853-2982
Additional location
1701 Divisadero St Fl 3
San Francisco, CA 941153011
(415) 353-7800
Mailing address
325 Distel Cir
Los Altos, CA 940221408

Credentials & registration

NPPES · NUCC
NPI registered
June 2018 — 8 yrs on file
Profile last updated
June 3, 2024
Year of graduation
2018 — 8 yrs since
Specialty taxonomy
207N00000X — NUCC code
State license (1)
California #A177012

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1902399751. Last verified May 11, 2026.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$225
Transactions
6
Manufacturers
3
Payer (manufacturer) Industry Txns Amount
Dermavant Sciences, INC. 4 $186.26
Incyte Corporation 1 $24.90
Leo Pharma INC. 1 $13.65

By nature of payment

Food and Beverage
$225

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
14
Patients
14
Total drug cost
$39
Drug Type Claims Patients Total cost
Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) Brand 14 14 $39

Frequently asked questions

Auto-generated from federal data
What is Dr. Rachel Rigo's medical specialty?
Dr. Rachel Rigo practices Dermatology Physician in Palo Alto, CA.
Where does Dr. Rachel Rigo practice?
Dr. Rachel Rigo practices at 795 El Camino Real, Palo Alto, CA 943012302. Office phone: 6508532982.
What is Dr. Rachel Rigo's NPI?
Dr. Rachel Rigo's National Provider Identifier (NPI) is 1902399751, issued by NPPES.
Does Dr. Rachel Rigo accept Medicare assignment?
Yes. Dr. Rachel Rigo accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.